Cellbricks Therapeutics
PrivateLast Round
Seed
Mar 25, 2026
Total Funding Raised
$10.07M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Cellbricks Therapeutics is a biotechnology company that develops biofabricated human tissue implants for regenerative medicine, reconstructive surgery, and wound healing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, 3D Printing, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cellbricks Therapeutics Comparables
Compare Cellbricks Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| FluidForm Bio | 78% | |
| Aspect Biosystems | 77% | |
| Trestle Biotherapeutics | 76% | |
Cellbricks Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 25, 2026 | ||||
| Seed | Sep 5, 2019 |
Key People
Founding team and executive leadership
Cellbricks Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Riceberg Ventures | Seed |
| Federal Ministry of Research, Technology, and Space | Grant |
| Federal Ministry for Economic Affairs and Energy | Grant |
| Silicon Roundabout Ventures | Seed |
| b.value AG | Seed |
| ACT Venture Partners | Seed |
| SPRIND | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 35, 121% of headcount.
- Mar 25, 2026
$10M raised in Seed round.
Cellbricks Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cellbricks Therapeutics's valuation, stock price, and market status.